Name: Ascentage Pharma Group International (AAPG) Financial Statements
Creator: FinSpry

Ascentage Pharma Group International Income Statement Analysis

Revenue, earnings, and profit margins in billions CNY

Scale:

Scroll to see more

Ascentage Pharma Group International income statement - Annual data in billions CNY
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.98	0.22	0.21	0.03	0.01
Cost of Revenue	0.03	0.03	0.02	0.00	0.00
Gross Profit	0.95	0.19	0.19	0.02	0.01
Operating Expenses
Research & Development	0.95	0.71	0.74	0.77	0.56
Selling, General & Administrative	0.38	0.38	0.33	0.19	0.13
Operating Expenses	1.32	1.06	1.04	0.96	0.69
Operating Income	-0.37	-0.87	-0.85	-0.93	-0.68
Other Income/Expense
Interest Income	0.04	0.03	0.01	0.01	0.01
Interest Expense	0.06	0.10	0.05	-0.02	-0.01
Other Income/Expense	-0.03	0.00	0.01	0.14	0.02
Income
Income Before Tax	-0.40	-0.93	-0.89	-0.83	-0.68
Income Tax Expense	0.01	-0.01	0.00	-0.05	0.00
Net Income	-0.41	-0.93	-0.88	-0.78	-0.68
Net Income - Continuous Operations	-0.41	-0.93	-0.88	-0.78	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-0.24	-0.74	-0.77	-0.92	-0.67
EBIT	-0.33	-0.84	-0.83	-0.93	-0.68
Depreciation & Amortization	0.09	0.09	0.06	0.02	0.02
Earnings Per Share
Basic EPS	-1.00	-13.00	-13.00	-3.00	-3.00
Diluted EPS	-1.00	-13.00	-13.00	-3.00	-3.00
Basic Shares Outstanding	0.30	0.07	0.07	0.25	0.22
Diluted Shares Outstanding	0.30	0.07	0.07	0.25	0.22